Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Research Study of Visilizumab for Treatment of Acute Graft Versus Host Disease

This study has been completed.
Information provided by (Responsible Party):
Facet Biotech Identifier:
First received: March 14, 2002
Last updated: March 9, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2006
  Primary Completion Date: August 2006 (Final data collection date for primary outcome measure)